CHC Healthcare logo

4164 - CHC Healthcare Share Price

TWD38.9 0.1  0.3%

Last Trade - 1:10am

Sector
Healthcare
Size
Small Cap
Market Cap £153.3m
Enterprise Value £236.6m
Revenue £69.1m
Position in Universe 2283rd / 5951
Bullish
Bearish
Unlock 4164 Revenue
Momentum
Relative Strength (%)
1m -7.09%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
2,091 2,395 2,205 2,117 2,507 2,950 3,192 +7.1%
-14.8 -24.7 -26.4 -41.1 +202.2 +25.5 +53.4
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, CHCHealthcare Group revenues decreased 15% to NT$1.19B. Netincome decreased 1% to NT$161.7M. Revenues reflect MedicalEquipment Sales segment decrease of 28% to NT$478M,Medicine Sales segment decrease of 17% to NT$84.4M. Netincome also reflects General and Administrative Expensesincrease of 13% to NT$94M (expense), Gain on FinancialAssets-Fair Value decrease of 61% to NT$4.1M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4164 Revenue Unlock 4164 Revenue

Net Income

4164 Net Income Unlock 4164 Revenue

Normalised EPS

4164 Normalised EPS Unlock 4164 Revenue

PE Ratio Range

4164 PE Ratio Range Unlock 4164 Revenue

Dividend Yield Range

4164 Dividend Yield Range Unlock 4164 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4164 EPS Forecasts Unlock 4164 Revenue
Profile Summary

CHC Healthcare Group is a Taiwan-based investment holding company. The Company primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. It also offers related maintenance and leasing services, components and consumable materials, as well as specialty consulting services. The Company deals with medical instrument with brands as Elekta, Nucletron, PTW Freiburg Gmb, TomoTherapy, Philips, International Specialty Products, Sonowand, Leica, Swissray, Yoshida, Heraeus, Carestream, Ritter, Bausch & Lomb, Technolas, Heine and Lumenis, among others.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated November 27, 2009
Public Since October 18, 2011
No. of Shareholders: 10,075
No. of Employees: 160
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Taiwan SE Weighted ,
Exchange Taiwan Stock Exchange
Shares in Issue 150,289,882
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4164 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4164
Upcoming Events for 4164
Frequently Asked Questions for CHC Healthcare
What is the CHC Healthcare share price?

As of 1:10am, shares in CHC Healthcare are trading at TWD38.9, giving the company a market capitalisation of £153.3m. This share price information is delayed by 15 minutes.

How has the CHC Healthcare share price performed this year?

Shares in CHC Healthcare are currently trading at TWD38.9 and the price has moved by -6.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CHC Healthcare price has moved by -16.66% over the past year.

What are the analyst and broker recommendations for CHC Healthcare?

Of the analysts with advisory recommendations for CHC Healthcare, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CHC Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will CHC Healthcare next release its financial results?

CHC Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the CHC Healthcare dividend yield?

The CHC Healthcare dividend yield is 5.15% based on the trailing twelve month period.

Does CHC Healthcare pay a dividend?

Last year, CHC Healthcare paid a total dividend of 2, and it currently has a trailing dividend yield of 5.15%. Looking ahead, CHC Healthcare has not announced an ex-dividend date yet.

When does CHC Healthcare next pay dividends?

CHC Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on CHC Healthcare shares is currently 5.15%.

How do I buy CHC Healthcare shares?

To buy shares in CHC Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CHC Healthcare?

Shares in CHC Healthcare are currently trading at TWD38.9, giving the company a market capitalisation of £153.3m.

Where are CHC Healthcare shares listed? Where are CHC Healthcare shares listed?

Here are the trading details for CHC Healthcare:

Country of listing: Taiwan
Exchange: TAI
Ticker Symbol: 4164
What kind of share is CHC Healthcare?

Based on an overall assessment of its quality, value and momentum, CHC Healthcare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CHC Healthcare share price forecast 2020?

We were not able to load any forecast data for CHC Healthcare.

How can I tell whether the CHC Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CHC Healthcare. Over the past six months, the relative strength of its shares against the market has been -23.6%. At the current price of TWD38.9, shares in CHC Healthcare are trading at 0.08% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CHC Healthcare PE Ratio?

The CHC Healthcare PE ratio based on its reported earnings over the past 12 months is 16.24. The shares are currently trading at TWD38.9.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of CHC Healthcare?

CHC Healthcare's management team is headed by:

Peilin Li - CHM
Dianying Li - VCH
Minglun Li - DGM
Yijun Chen - FID
Junxiong Huang - DRC
Sporn Chen - IND
Changjian He - IND
Yimin Ren - OTH
Yung-Shun Chuang - DRC
Gengwang Liao - IND
Who are the major shareholders of CHC Healthcare?

Here are the top five shareholders of CHC Healthcare based on the size of their shareholding:

Princeton Healthcare Limited Corporation
Percentage owned: 18.68% (28.3m shares)
Li (Tien Ying) Individual Investor
Percentage owned: 6.22% (9.41m shares)
Yi Zhan Xin Co., Ltd. Corporation
Percentage owned: 4.83% (7.30m shares)
Li (Pei Lin-a) Individual Investor
Percentage owned: 3.76% (5.68m shares)
Fubon Life Insurance Co., Ltd. Insurance Company
Percentage owned: 3.56% (5.39m shares)
Similar to 4164
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.